A Drug‑resistant Stomach Bug Is Spreading, CDC Warns
The CDC says drug-resistant infections rose nearly 8.5% from 2011 to 2023, and about one-third of patients were hospitalized.
4 Articles
4 Articles
A drug‑resistant stomach bug is spreading, CDC warns
Federal health officials are sounding the alarm over a fast-spreading, drug‑resistant strain of shigella that causes severe diarrhea and has no FDA‑approved oral treatment — a development the U.S. Centers for Disease Control and Prevention now calls “a public health threat.”
Drug-resistant Shigella bacteria on the rise in US, CDC study reveals: What to know
A drug resistant Shigella bacteria is on the rise in the United States, according to the Center for Disease Control and Prevention. According to a report by the CDC published on April 9, there was a nearly 8.5% increase from 2011 to 2023 in Shigella infections that are drug resistance. “Whereas earlier U.S. outbreaks involved drug-susceptible strains and primarily affected children, national surveillance data indicate that most XDR cases occurre…
Diarrhea-Causing Germs Rotavirus and Drug-Resistant Shigella Are Rising in U.S.
Cases of two different types of severe diarrhea -causing illnesses are on the rise in the United States. Rotavirus and drug-resistant shigella bacteria aren’t the most common causes of diarrheal illness in the country, but the increasing rates are concerning, according to infectious disease doctors. “ Norovirus is still the king of diarrheal illness,” says Thomas Russo, MD , chief of infectious diseases at the University at Buffalo in New York. …
Emergence of Extensively Drug-Resistant Shigellosis — United States, 2011–2023
The Centers for Disease Control and Prevention MMWR report (Vol. 75, No. 13) documents a concerning rise of extensively drug-resistant (XDR) Shigella infections in the United States between 2011 and 2023: the proportion of isolates classified as XDR increased from 0% to 8.5%, with these strains resistant to all commonly used first-line antibiotics and no FDA-approved oral treatment options available. The infections are increasingly observed in a…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


